Indegene to Acquire the Multi-channel, e-Detailing and Physician Marketing Services Business Assets of Canada-based Aptilon, to Help Clients Accelerate Their Physician Engagement Strategies
ISELIN, New Jersey, November 9, 2012 /PRNewswire/ --
Indegene, a leading provider of R&D, commercial and marketing solutions to top global pharmaceutical and healthcare organizations, today announced a definitive agreement to acquire the multi-channel, video and e-detailing, and physician marketing services business of Aptilon Holdings Inc., a wholly owned subsidiary of Aptilon Corporation.
Aptilon, headquartered in Canada, is a pioneer and a leader in providing e-marketing solutions for several large pharmaceutical, biotech and healthcare clients in the United States, Canada and Europe. Aptilon enables clients to effectively reach, connect and interact with over 500,000 physicians and healthcare professionals via multiple access channels including iPADs, mobile and desktop media. Its innovative service and platform offerings, including Live Central and Channel HQ, provide targeted impressions and interactions through "click-to-talk" video and mobile detailing, digital access "on-demand" channels and permission-based e-mail services that drive efficient physician recruitment and outcomes.
The need for intelligent, robust, and outcome-driven multi-channel marketing (MCM) and Virtual/Inside Sales programs is estimated to represent a USD 10 billion opportunity as companies continue to accelerate the transformation of their sales and marketing organizations over the next 4-5 years.
Manish Gupta, CEO, Indegene, said: "By combining Indegene's Virtual/Inside Sales and MCM capabilities with Aptilon's technology platforms, significant physician reach, and multi-year data on physician behavior in the North American and European market, clients can accelerate their physician engagement strategies and deploy true end-to-end world-class programs."
Denis Martineau, President, Aptilon Holdings Inc., added: "Aptilon has been a leading provider of world-class e-marketing, remote detailing and multi-channel marketing programs. Through this proposed transaction, our clients will gain access to an accelerated approach to drive integrated physician engagement programs. In addition, our clients can leverage global expertise and infrastructure assets in US, Europe and Emerging Markets to enhance productivity as well as effectiveness."
Upon completion of the acquisition, Aptilon's multi-channel, e-detailing, and physician marketing services businesses will be rolled under Indegene Aptilon, Inc. - a wholly-owned subsidiary of Indegene Lifesystems Pvt. Ltd.
Dr. Rajesh Nair, President, Indegene, said: "Indegene has been a leading provider of digital and multi-channel marketing solutions to global pharma since early adopters started to transform their sales and marketing organizations. We have implemented close to 100 global and local programs, and now have over 300 full-time MCM and Virtual/Inside sales professionals based in US, India and China. We have also added over 20 strategic contact center partnerships globally to enable clients to deploy multi-country/multi-regional/multi-lingual sales and MCM programs for both new and mature products."
Dr. Nair added: "This acquisition presents us with a unique opportunity to further consolidate our Virtual/Inside sales offering. We expect the synergies of this acquisition to create around 200 new jobs
in USA and Canada, and an additional 1,000 jobs in India and China as we ramp up to address this need. We expect to complete this transaction in the next few weeks subject to customary closing conditions including obtaining necessary approvals from regulatory authorities."
Indegene is a leading provider of R&D, commercial and marketing solutions to global pharmaceutical and healthcare organizations. We partner with clients to drive both productivity and revenues by delivering better patient outcomes, optimizing cost, enhancing R&D agility, and improving sales and marketing effectiveness. We apply deep scientific knowledge, flexible delivery models, proprietary technology, and a client-centric approach to drive transformational initiatives.
With offices in US, UK, China, India, and Australia, Indegene can partner globally with clients; leverage a global talent pool of clinicians, technologists, creative specialists, domain experts, and business process specialists; deploy global infrastructure assets; and harness global healthcare knowledge to solve client challenges. For more information, visit http://www.indegene.com.
Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach, message, connect, and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through video and mobile detailing, digital access channels and permission-based e-mail services. Top pharmaceutical companies and respected healthcare organizations have adopted Aptilon's solutions to market to, engage and interact with leading healthcare practitioners. For more information, visit http://www.indegeneaptilon.com.
US and Europe
Ann Marie Craggan
SOURCE Indegene Lifesystems Pvt Ltd